what would you tell week-1 you about biopsy
Been lurking in c/dosinglogs for about 5 months and finally have something worth posting.
Short version: week 21, 0.5mg, and glucagon is the bit I still cannot get a straight answer on. I have read the wiki, I have read the last 17 threads, and the answers split roughly down the middle.
What I actually want to know is whether the people saying it does not matter have measured it, or whether it is just repeated confidently. Happy to be told I am overthinking this — I probably am — but I would rather overthink it now than at week 27.
best — the order this archive was captured in
Hepatic fat or MASH or what?
glucagon co-agonism has a different safety story
Yeah, glucagon co-agonism is genuinely different.
Yeah, glucagon co-agonism is genuinely different.
Stalled for 24 weeks, changed nothing, and it started moving again on week 33.
Stalled for 12 weeks, changed nothing, and it started moving again on week 82.
glucagon injection is a different vector than GLP-1
the safety profile is not just tirzepatide amplified
I am going to push back on this slightly.
rodent dual agonist is investigation only
Retitled to remove editorialising. Put the evidence in the body.
the safety profile is not just tirzepatide amplified
- 1genuinely useful, thanks4 comments in this branch · started by u/tired_ledger_ftw
- 2rodent dual agonist is investigation only4 comments in this branch · started by u/valeria_karlsen